Laddar...
Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer
Approximately 20%–25% of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor. This overexpression is associated with aggressive disease, relatively poor prognosis, and worse clinical outcomes. N...
Sparad:
Huvudupphovsmän: | , , |
---|---|
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Hindawi Publishing Corporation
2013
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3676960/ https://ncbi.nlm.nih.gov/pubmed/23762609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/362467 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|